US Stock MarketDetailed Quotes

BBLG Bone Biologics

Watchlist
  • 1.0100
  • -0.0400-3.81%
Close Dec 20 16:00 ET
  • 0.9700
  • -0.0400-3.96%
Post 20:01 ET
2.49MMarket Cap-0.29P/E (TTM)

Bone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-19.90%3.57M
-66.72%2.33M
-47.84%3.23M
-59.85%3.03M
-59.85%3.03M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
12.93%7.54M
-Cash and cash equivalents
-19.90%3.57M
-66.72%2.33M
-47.84%3.23M
-59.85%3.03M
-59.85%3.03M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
12.93%7.54M
Prepaid assets
-4.65%499.39K
40.01%861.4K
2.77%611.94K
-25.68%711.19K
-25.68%711.19K
269.54%523.76K
201.06%615.24K
113.32%595.43K
--956.93K
--956.93K
Total current assets
-18.30%4.07M
-58.11%3.19M
-43.40%3.84M
-56.00%3.74M
-56.00%3.74M
-4.32%4.98M
34.71%7.62M
11.32%6.78M
27.26%8.5M
27.26%8.5M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-18.30%4.07M
-58.11%3.19M
-43.40%3.84M
-56.00%3.74M
-56.00%3.74M
-4.32%4.98M
34.71%7.62M
11.32%6.78M
27.26%8.5M
27.26%8.5M
Liabilities
Current liabilities
Payables
--190.06K
--231.87K
--146.19K
244.19%360.66K
244.19%360.66K
----
----
----
--104.79K
--104.79K
-accounts payable
--190.06K
--231.87K
--146.19K
244.19%360.66K
244.19%360.66K
----
----
----
--104.79K
--104.79K
Current accrued expenses
--0
--0
----
----
----
----
----
----
----
----
Current deferred liabilities
--65.72K
--44.98K
----
--0
--0
----
----
----
--783.68K
--783.68K
Other current liabilities
-78.10%17.63K
-96.83%7.66K
-98.94%18.44K
-71.63%470.74K
-71.63%470.74K
--80.51K
--241.16K
--1.73M
--1.66M
--1.66M
Current liabilities
-76.89%273.4K
-85.26%284.51K
-95.90%164.63K
-67.37%831.4K
-67.37%831.4K
48.00%1.18M
2,632.68%1.93M
7,204.93%4.01M
2,450.25%2.55M
2,450.25%2.55M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-76.89%273.4K
-85.26%284.51K
-95.90%164.63K
-67.37%831.4K
-67.37%831.4K
48.00%1.18M
2,632.68%1.93M
7,204.93%4.01M
2,450.25%2.55M
2,450.25%2.55M
Shareholders'equity
Share capital
-33.14%2.1K
-58.05%1.32K
-93.92%1.02K
734.38%534
734.38%534
-69.71%3.14K
-69.71%3.14K
61.36%16.7K
-99.38%64
-99.38%64
-common stock
-33.14%2.1K
-58.05%1.32K
-93.92%1.02K
734.38%534
734.38%534
-69.71%3.14K
-69.71%3.14K
61.36%16.7K
-99.38%64
-99.38%64
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-5.22%-83.5M
-6.61%-82.56M
-8.07%-81.77M
-12.44%-80.91M
-12.44%-80.91M
-8.93%-79.36M
-8.10%-77.44M
-6.33%-75.67M
-2.11%-71.96M
-2.11%-71.96M
Paid-in capital
4.98%87.29M
2.81%85.47M
8.96%85.45M
7.58%83.81M
7.58%83.81M
7.64%83.15M
7.66%83.13M
1.60%78.43M
1.13%77.91M
1.13%77.91M
Total stockholders'equity
-0.02%3.79M
-48.90%2.91M
32.55%3.67M
-51.13%2.91M
-51.13%2.91M
-13.82%3.79M
1.87%5.69M
-54.09%2.77M
-9.55%5.95M
-9.55%5.95M
Total equity
-0.02%3.79M
-48.90%2.91M
32.55%3.67M
-51.13%2.91M
-51.13%2.91M
-13.82%3.79M
1.87%5.69M
-54.09%2.77M
-9.55%5.95M
-9.55%5.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -19.90%3.57M-66.72%2.33M-47.84%3.23M-59.85%3.03M-59.85%3.03M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M12.93%7.54M
-Cash and cash equivalents -19.90%3.57M-66.72%2.33M-47.84%3.23M-59.85%3.03M-59.85%3.03M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M12.93%7.54M
Prepaid assets -4.65%499.39K40.01%861.4K2.77%611.94K-25.68%711.19K-25.68%711.19K269.54%523.76K201.06%615.24K113.32%595.43K--956.93K--956.93K
Total current assets -18.30%4.07M-58.11%3.19M-43.40%3.84M-56.00%3.74M-56.00%3.74M-4.32%4.98M34.71%7.62M11.32%6.78M27.26%8.5M27.26%8.5M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -18.30%4.07M-58.11%3.19M-43.40%3.84M-56.00%3.74M-56.00%3.74M-4.32%4.98M34.71%7.62M11.32%6.78M27.26%8.5M27.26%8.5M
Liabilities
Current liabilities
Payables --190.06K--231.87K--146.19K244.19%360.66K244.19%360.66K--------------104.79K--104.79K
-accounts payable --190.06K--231.87K--146.19K244.19%360.66K244.19%360.66K--------------104.79K--104.79K
Current accrued expenses --0--0--------------------------------
Current deferred liabilities --65.72K--44.98K------0--0--------------783.68K--783.68K
Other current liabilities -78.10%17.63K-96.83%7.66K-98.94%18.44K-71.63%470.74K-71.63%470.74K--80.51K--241.16K--1.73M--1.66M--1.66M
Current liabilities -76.89%273.4K-85.26%284.51K-95.90%164.63K-67.37%831.4K-67.37%831.4K48.00%1.18M2,632.68%1.93M7,204.93%4.01M2,450.25%2.55M2,450.25%2.55M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -76.89%273.4K-85.26%284.51K-95.90%164.63K-67.37%831.4K-67.37%831.4K48.00%1.18M2,632.68%1.93M7,204.93%4.01M2,450.25%2.55M2,450.25%2.55M
Shareholders'equity
Share capital -33.14%2.1K-58.05%1.32K-93.92%1.02K734.38%534734.38%534-69.71%3.14K-69.71%3.14K61.36%16.7K-99.38%64-99.38%64
-common stock -33.14%2.1K-58.05%1.32K-93.92%1.02K734.38%534734.38%534-69.71%3.14K-69.71%3.14K61.36%16.7K-99.38%64-99.38%64
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -5.22%-83.5M-6.61%-82.56M-8.07%-81.77M-12.44%-80.91M-12.44%-80.91M-8.93%-79.36M-8.10%-77.44M-6.33%-75.67M-2.11%-71.96M-2.11%-71.96M
Paid-in capital 4.98%87.29M2.81%85.47M8.96%85.45M7.58%83.81M7.58%83.81M7.64%83.15M7.66%83.13M1.60%78.43M1.13%77.91M1.13%77.91M
Total stockholders'equity -0.02%3.79M-48.90%2.91M32.55%3.67M-51.13%2.91M-51.13%2.91M-13.82%3.79M1.87%5.69M-54.09%2.77M-9.55%5.95M-9.55%5.95M
Total equity -0.02%3.79M-48.90%2.91M32.55%3.67M-51.13%2.91M-51.13%2.91M-13.82%3.79M1.87%5.69M-54.09%2.77M-9.55%5.95M-9.55%5.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List